NO20030717L - Forbindelser for behandling av avhengighetsforstyrrelser - Google Patents
Forbindelser for behandling av avhengighetsforstyrrelserInfo
- Publication number
- NO20030717L NO20030717L NO20030717A NO20030717A NO20030717L NO 20030717 L NO20030717 L NO 20030717L NO 20030717 A NO20030717 A NO 20030717A NO 20030717 A NO20030717 A NO 20030717A NO 20030717 L NO20030717 L NO 20030717L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- treatment
- addiction disorders
- addiction
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22571400P | 2000-08-16 | 2000-08-16 | |
US26361001P | 2001-01-23 | 2001-01-23 | |
PCT/US2001/025603 WO2002013807A2 (en) | 2000-08-16 | 2001-08-13 | Compounds for the treatment of addictive disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030717L true NO20030717L (no) | 2003-02-14 |
NO20030717D0 NO20030717D0 (no) | 2003-02-14 |
Family
ID=26919847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030717A NO20030717D0 (no) | 2000-08-16 | 2003-02-14 | Forbindelser for behandling av avhengighetsforstyrrelser |
Country Status (17)
Country | Link |
---|---|
US (2) | US6841557B2 (no) |
EP (1) | EP1363634A2 (no) |
JP (1) | JP2004506621A (no) |
KR (1) | KR20030024877A (no) |
AR (1) | AR030364A1 (no) |
AU (2) | AU2001283393B2 (no) |
BR (1) | BR0112939A (no) |
CA (1) | CA2413762A1 (no) |
CZ (1) | CZ200380A3 (no) |
EA (1) | EA200300271A1 (no) |
IL (1) | IL154378A0 (no) |
MX (1) | MXPA03001472A (no) |
NO (1) | NO20030717D0 (no) |
NZ (1) | NZ524741A (no) |
PE (1) | PE20020288A1 (no) |
PL (1) | PL363365A1 (no) |
WO (1) | WO2002013807A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
MXPA05003513A (es) * | 2002-10-04 | 2005-06-03 | Pharmacia Corp | Composiciones farmaceuticas para tratamiento de enfermedad de parkinson. |
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
DK2618826T3 (en) * | 2010-09-20 | 2016-08-01 | A Carlsson Res Ab | Phenylpiperdine FOR TREATMENT OF DEMENTIA |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526892A (en) | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
US4935429A (en) * | 1985-10-25 | 1990-06-19 | Dackis Charles A | Method of treating psychostimulant addiction |
US4800204A (en) * | 1987-05-07 | 1989-01-24 | Mueller Peter S | Method of controlling tobacco use |
US4999382A (en) * | 1988-10-26 | 1991-03-12 | Massachusetts Institute Of Technology | Compositions for treating tobacco withdrawal symptoms and methods for their use |
US5273975A (en) | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
HU210264B (en) * | 1989-06-09 | 1995-03-28 | Upjohn Co | Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them |
US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
WO1992000282A1 (en) * | 1990-06-29 | 1992-01-09 | The Upjohn Company | Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity |
JP3176063B2 (ja) | 1991-04-17 | 2001-06-11 | ファルマシア・アンド・アップジョン・カンパニー | 新規中枢神経作用性置換フェニルアザシクロアルカン類 |
TW252979B (no) * | 1992-12-24 | 1995-08-01 | Erba Carlo Spa | |
CN1046723C (zh) * | 1993-04-06 | 1999-11-24 | 艾博特公司 | 四环化合物、含有它们的药物组合物及其用途 |
ATE182590T1 (de) | 1993-12-28 | 1999-08-15 | Upjohn Co | Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen |
GB9407637D0 (en) * | 1994-04-18 | 1994-06-08 | Erba Carlo Spa | Serotoninergic abeo-ergoline derivatives |
US5874477A (en) * | 1994-08-12 | 1999-02-23 | The University Of Hawaii | Method of treatment for malaria utilizing serotonin receptor ligands |
IL122649A (en) * | 1995-08-11 | 2001-08-26 | Pfizer | (1s, 2s) - 1- (4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate, its use in the preparation of medicaments and pharmaceutical compositions comprising same |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
GB9603226D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Heterocyclyl-ergoline derivatives |
US6001848A (en) * | 1996-03-25 | 1999-12-14 | The Regents Of The University Of California | Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele |
HN1998000118A (es) * | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
GB9723544D0 (en) * | 1997-11-07 | 1998-01-07 | Merck Sharp & Dohme | Therapeutic agents |
US20020010197A1 (en) * | 1998-01-13 | 2002-01-24 | John Dixon | Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity |
US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
CA2405565A1 (en) * | 2000-04-21 | 2001-11-01 | Pharmacia & Upjohn Company | Compounds for treating fibromyalgia and chronic fatigue syndrome |
-
2001
- 2001-08-13 NZ NZ524741A patent/NZ524741A/en unknown
- 2001-08-13 EP EP01962196A patent/EP1363634A2/en not_active Withdrawn
- 2001-08-13 BR BR0112939-2A patent/BR0112939A/pt not_active IP Right Cessation
- 2001-08-13 EA EA200300271A patent/EA200300271A1/ru unknown
- 2001-08-13 AU AU2001283393A patent/AU2001283393B2/en not_active Ceased
- 2001-08-13 PL PL01363365A patent/PL363365A1/xx not_active Application Discontinuation
- 2001-08-13 MX MXPA03001472A patent/MXPA03001472A/es not_active Application Discontinuation
- 2001-08-13 IL IL15437801A patent/IL154378A0/xx unknown
- 2001-08-13 KR KR10-2003-7002252A patent/KR20030024877A/ko not_active Application Discontinuation
- 2001-08-13 CA CA002413762A patent/CA2413762A1/en not_active Abandoned
- 2001-08-13 WO PCT/US2001/025603 patent/WO2002013807A2/en not_active Application Discontinuation
- 2001-08-13 JP JP2002518953A patent/JP2004506621A/ja active Pending
- 2001-08-13 CZ CZ200380A patent/CZ200380A3/cs unknown
- 2001-08-13 AU AU8339301A patent/AU8339301A/xx active Pending
- 2001-08-14 US US09/929,666 patent/US6841557B2/en not_active Expired - Fee Related
- 2001-08-16 PE PE2001000816A patent/PE20020288A1/es not_active Application Discontinuation
- 2001-08-16 AR ARP010103925A patent/AR030364A1/es unknown
-
2002
- 2002-11-15 US US10/295,331 patent/US20030078273A1/en not_active Abandoned
-
2003
- 2003-02-14 NO NO20030717A patent/NO20030717D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL363365A1 (en) | 2004-11-15 |
JP2004506621A (ja) | 2004-03-04 |
EP1363634A2 (en) | 2003-11-26 |
NZ524741A (en) | 2005-01-28 |
KR20030024877A (ko) | 2003-03-26 |
WO2002013807A2 (en) | 2002-02-21 |
AU2001283393B2 (en) | 2005-09-22 |
BR0112939A (pt) | 2005-11-01 |
US20020049206A1 (en) | 2002-04-25 |
IL154378A0 (en) | 2003-09-17 |
EA200300271A1 (ru) | 2004-02-26 |
AR030364A1 (es) | 2003-08-20 |
MXPA03001472A (es) | 2003-06-06 |
CA2413762A1 (en) | 2002-02-21 |
PE20020288A1 (es) | 2002-03-31 |
US20030078273A1 (en) | 2003-04-24 |
WO2002013807A3 (en) | 2003-09-25 |
AU8339301A (en) | 2002-02-25 |
NO20030717D0 (no) | 2003-02-14 |
US6841557B2 (en) | 2005-01-11 |
CZ200380A3 (cs) | 2004-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
NO20043237L (no) | Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser | |
NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
NO20031443L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
EP1274444A4 (en) | DRUGS FOR THE TREATMENT OF PSYCHIATRICAL OR ABUSUS-RELATED DISORDER | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
NO20023803D0 (no) | Anvendelse av mirtazapin for behandling av sövnforstyrrelser | |
NO20030717D0 (no) | Forbindelser for behandling av avhengighetsforstyrrelser | |
NO20032156D0 (no) | Behandling av angstforstyrrelser | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser | |
NO20024887L (no) | FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |